Clinical Trial Update: A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two EYS606 regimens for active chronic non-infectious uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• EYS606

Snippet

Sponsor: Eyevensys | Conditions: Non-infectious Uveitis | Phase 2 | Status: COMPLETED